FDA Approves 4 Updated COVID-19 Vaccines for 2026–2027 Season

The FDA has approved four updated COVID-19 vaccines that target the XFG variant. Luis Alvarez · DigitalVision/Getty The Food and Drug Administration (FDA) has approved four updated COVID-19 vaccines for the 2026–2027 season, all targeting the JN.1-lineage XFG variant. All four vaccines are approved for adults ages 65 and older, as well as younger people with underlying conditions that put them at higher risk of severe COVID-19, with eligibility varying by vaccine. The updated vaccines are designed to provide protection against currently circulating COVID-19 variants ahead of the fall and winter season. On August 27, the Food and Drug Administration (FDA) announced approval of four updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech for the 2026–2027 season. Each of these updated vaccines is designed to target the JN.1-lineage XFG variant, which is currently the most prevalent globally. The updated vaccines are approved for all adults ages 65 and older, as well as younger people with underlying conditions that put them at higher risk of severe COVID-19. What are the four approved COVID-19 vaccines? While all of these updated vaccines target the same variant,…

≈